Results 151 to 160 of about 1,854,049 (378)

PCN64 Frequency of ORAL Mucositis in Male Patients Receiving Cancer Therapy [PDF]

, 2020
Abhijna Vithal Yergolkar, P. Gundala, M. Krishna Murthy, V.M. Vinayak   +3 more
openalex   +1 more source

The protective effect of bosentan on methotrexate-induced oral mucositis in rats [PDF]

, 2023
Rana Khairi Attarbashee, Jawnaa Mammdoh, Sahar G. Al-Kazzaz   +2 more
openalex   +1 more source

Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis

Medicina, 2019
Background and objectives: Oral mucositis is one of the main adverse events of cancer treatment with chemotherapy or radiation therapy. It presents as erythema, atrophy or/and ulceration of oral mucosa.
Goda Daugėlaitė, Kristė Užkuraitytė, E. Jagelavičienė, Aleksas Filipauskas   +3 more
semanticscholar   +1 more source

Oral mucosal hyperpigmentation [PDF]

JAAD Case Reports, 2020
Karen Lee, BS, Christine Lian, MD, Anand Vaidya, MD, Hillary C. Tsibris, MD   +3 more
openaire   +3 more sources

Beyond Tumor Control: A Protocol for Multidimensional Assessment of Long‐Term Effects of Intensity‐Modulated Radiotherapy on Vision, Patient Well‐Being, and Morbidity in Head and Neck Cancer

Med Research, EarlyView.
Benjamin Abaidoo, Hannah Ayettey, Andrew Elikem Akafo, Naa N. Tagoe, Mildred Johnson, Vera Adobea Essuman, Edith Dogbe   +6 more
wiley   +1 more source

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA‐VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia

British Journal of Haematology, EarlyView.
Summary Induction chemotherapy in fit de novo acute myeloid leukaemia (AML) patients has historically combined an anthracycline with standard‐dose cytarabine (‘7 + 3’) despite complete response (CR) rates of 50%–70%. In May 2023, our institution adopted the utilization of cladribine, cytarabine, idarubicin and venetoclax (CLIA‐VEN) for intensive ...
Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Anthony Quach, Yujiao Sun, Piyatida Chumnumsiriwath, Stefan O. Ciurea, Jorge Ramos‐Perez, Polina Bellman, Deepa Jeyakumar, Piyanuch Kongtim, Kiran Naqvi   +11 more
wiley   +1 more source

Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis

Current Treatment Options in Oncology, 2022
Charles T. Lee, T. Galloway
semanticscholar   +1 more source

Antimicrobial‐Releasing Implant Substrates for Combating Oral Biofilms: An In Vitro Study

Clinical Oral Implants Research, EarlyView.
ABSTRACT Background and Objectives Peri‐implantitis, a biofilm‐associated inflammatory disease, significantly threatens dental implant longevity. Current treatments face limitations due to biofilm robustness. This study evaluates the efficacy of antimicrobial‐releasing titanium‐silica (Ti/SiO2) composite implant systems against multispecies oral ...
Nur Hidayatul Nazirah Kamarudin, Lars Vanmunster, Brecht Van Hooreweder, Kenneth Siemons, Kristel Bernaerts, Wim Teughels, Annabel Braem, Naiera Zayed   +7 more
wiley   +1 more source

Clinical and Radiographic Performance of Two Distinct Sandblasted, Large‐Grit, Acid‐Etched Implant Surfaces: A Split‐Mouth Randomized Clinical Trial

Clinical Oral Implants Research, EarlyView.
ABSTRACT Aim To compare the clinical performance of two sandblasted, large‐grit, acid‐etched implant surfaces regarding changes in radiographic marginal bone level (MBL) 12 months after loading. Materials and Methods In this randomized, split‐mouth, dual‐center clinical trial, each patient received one test (modified hydrophilic surface) implant and ...
Blanca Vílchez, Leticia Caneiro, Cristina Lima, Ignacio Sanz‐Sánchez, Eduardo Montero, Elena Figuero, Juan Blanco, Mariano Sanz   +7 more
wiley   +1 more source

Effect of Oral Zinc Sulphate in Preventionof Radiation Induced OropharyngealMucositis During and After Radiotherapyin Patients with Head and Neck Cancers

Middle East Journal of Cancer, 2010
Introduction:Mucositis is a disturbing side effect of radiotherapy treatment forhead and neck cancer. To date, no effective modality for its prophylaxis and treatmenthas been found. We performed this study to evaluate the efficacy of oral zincsulphate in
Mohammad Mohammadianpanah, Shapour Omidvari, Mohammad Amin Mosleh-Shirazi, Mansour Ansari, Niloofar Ahmadloo, Hamid Nasrolahi, Ahmad Mosalaei, Amin Shafizad   +7 more
doaj